Measures · D03 in 2021 · Part D · DD1 Drug Plan Customer Service
Appeals Upheld
AppealsDrug PlanSource: Independent Review Entity
- What it measures
- How often an independent reviewer thought the drug plan’s decision to deny an appeal was fair. This includes appeals made by plan members and out-of-network providers. (This rating is not based on how often the plan denies appeals, but rather how fair the plan is when they deny an appeal.)
- How it's calculated
- This measure is defined as the percent of IRE confirmations of upholding the plans’ decisions. This is calculated as: [(Number of cases upheld) / (Total number of cases reviewed)] * 100. Total number of cases reviewed is defined all cases received by the IRE during the timeframe and receiving a decision before May 1, 2020. The denominator is equal to the number of cases upheld, fully reversed, and partially reversed. Dismissed, remanded, and withdrawn cases are not included in the denominator. Auto-forwarded cases are included, as these are considered to be adverse decisions per Subpart M rules. If a Reopening occurs and is decided prior to May 1, 2020, the Reopened decision is used in place of the Reconsideration decision. Reopenings decided on or after May 1, 2020 are not reflected in these data the original decision result is used. The results of appeals that occur beyond Level 2 (i.e., Administrative Law Judge or Medicare Appeals Council appeals) are not included in the data. Contracts with no IRE cases reviewed will not receive a score in this measure.
- Data source
- Independent Review Entity (IRE) Data were obtained from the Independent Review Entity (IRE) contracted by CMS for Part D reconsiderations. The appeals used in this measure are based on the date they were received by the IRE, not the date a decision was reached by the IRE.
- Measurement period
- 01/01/2019 – 12/31/2019
- Better when
- Higher
- Weight
- 2 (Measures Capturing Access)
- Star assignment
- Clustering
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- No
- Exclusions
Show
Contracts with fewer than 10 cases reviewed by the IRE.- Disaster policy
- Higher measure star (2020-2021) for contracts with 25% or more enrolled affected by 2019 disasters.
From the 2021 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2021 star distribution
Not rated: Not enough data available (353); Plan too new to be measured (186); No data available (39); Plan not required to report measure (9)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2021 | MA-PD | < 79 % | >= 79 % to < 85 % | >= 85 % to < 89 % | >= 89 % to < 95 % | >= 95 % |
| 2021 | PDP | < 80 % | >= 80 % to < 87 % | >= 87 % to < 93 % | >= 93 % to < 97 % | >= 97 % |
| 2020 | MA-PD | < 71% | ? 71% to < 78% | ? 78% to < 86% | ? 86% to < 94% | ? 94% |
| 2020 | PDP | < 80% | ? 80% to < 84% | ? 84% to < 90% | ? 90% to < 94% | ? 94% |
| 2019 | MA-PD | < 60% | ? 60% to < 69% | ? 69% to < 81% | ? 81% to < 92% | ? 92% |
| 2019 | PDP | < 64% | ? 64% to < 78% | ? 78% to < 89% | ? 89% to < 91% | ? 91% |
| 2018 | MA-PD | < 56% | ? 56% to < 71% | ? 71% to < 79% | ? 79% to < 89% | ? 89% |
| 2018 | PDP | < 61% | ? 61% to < 71% | ? 71% to < 81% | ? 81% to < 92% | ? 92% |
| 2017 | MA-PD | < 47% | ? 47% to < 66% | ? 66% to < 78% | ? 78% to < 88% | ? 88% |
| 2017 | PDP | < 60% | ? 60% to < 66% | ? 66% to < 77% | ? 77% to < 91% | ? 91% |
| 2016 | MA-PD | < 42% | ? 42% to < 60% | ? 60% to < 73% | ? 73% to < 88% | ? 88% |
| 2016 | PDP | < 54% | ? 54% to < 65% | ? 65% to < 76% | ? 76% to < 91% | ? 91% |
| 2015 | MA-PD | < 50% | ? 50% to < 60% | ? 60% to < 72% | ? 72% to < 84% | ? 84% |
| 2015 | PDP | < 48% | ? 48% to < 58% | ? 58% to < 68% | ? 68% to < 78% | ? 78% |
Lowest-scoring contracts, 2021
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S5916 Regence BlueShield of Idaho and Regence BC BS Utah | Cambia Health Solutions, Inc. | 1,098 | 69 | 1 | — | 24 | 0% |
| H2261 Blue Cross Blue Shield of Massachusetts | Blue Cross and Blue Shield of Massachusetts, Inc. | 42,510 | 60 | 1 | — | 29 | 0% |
| H5533 UPMC for Life | UPMC Health System | 58,457 | 64 | 1 | — | 25 | 1% |
| H3962 Capital Blue Cross | CAPITAL BLUE CROSS | 8,238 | 70 | 1 | −4 | 19 | 1% |
| R0923 Humana | Humana Inc. | — | 70 | 1 | — | 19 | 1% |
| H1994 Select Health | Intermountain Health Care, Inc. | 67,364 | 71 | 1 | 0 | 18 | 2% |
| S5596 Anthem Insurance Companies, Inc. | Elevance Health, Inc. | 59,830 | 75 | 1 | −4 | 18 | 3% |
| H2230 Blue Cross Blue Shield of Massachusetts | Blue Cross and Blue Shield of Massachusetts, Inc. | 45,136 | 72 | 1 | −2 | 17 | 3% |
| H0351 Wellcare | Centene Corporation | 23,066 | 72 | 1 | −1 | 17 | 3% |
| H4605 Regence BlueCross BlueShield of Utah | Cambia Health Solutions, Inc. | 7,291 | 73 | 1 | — | 16 | 4% |
| H5580 Mercy Care Advantage | Mercy Care | 10,965 | 73 | 1 | −2 | 16 | 4% |
| H0473 Humana | Humana Inc. | 16,154 | 73 | 1 | — | 16 | 4% |
| H4279 UPMC for Life Complete Care | UPMC Health System | 37,410 | 73 | 1 | −3 | 16 | 4% |
| S6506 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | — | 77 | 1 | −4 | 16 | 5% |
| H0302 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | 38,702 | 74 | 1 | −2 | 15 | 6% |
| H3924 Geisinger Gold | Risant Health, Inc. | 24,445 | 75 | 1 | — | 14 | 6% |
| H5009 Regence BlueShield | Cambia Health Solutions, Inc. | 10,384 | 75 | 1 | 0 | 14 | 6% |
| H5945 Prominence Health Plan | Universal Health Services, Inc. | 23,720 | 76 | 1 | — | 13 | 7% |
| S5609 Asuris Northwest Health | Cambia Health Solutions, Inc. | 279 | 80 | 2 | 0 | 13 | 8% |
| H1610 Aetna Medicare | CVS Health Corporation | 10,909 | 77 | 1 | — | 12 | 8% |
| H3813 Moda Health Plan, Inc. | Moda Partners, Inc. | — | 77 | 1 | 0 | 12 | 8% |
| H5649 Central Health Medicare Plan | Molina Healthcare, Inc. | 30,678 | 77 | 1 | — | 12 | 8% |
| R4182 Humana | Humana Inc. | 12,033 | 79 | 2 | −2 | 10 | 10% |
| H3384 Highmark Blue Cross Blue Shield or Highmark Blue Shield | Highmark Health | 22,566 | 79 | 2 | −1 | 10 | 10% |
| S5975 Moda Health Plan, Inc. | Moda Partners, Inc. | 58,300 | 82 | 1 | −1 | 11 | 10% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2021 | D03 | Appeals Upheld | 01/01/2019 – 12/31/2019 | 2 | Independent Review Entity |
| 2020 | D03 | Appeals Upheld | 01/01/2018– 12/31/2018 | 1.5 | Independent Review Entity |
| 2019 | D03 | Appeals Upheld | 01/01/2017 – 12/31/2017 | 1.5 | Independent Review Entity |
| 2018 | D03 | Appeals Upheld | 01/01/2016 – 12/31/2016 | 1.5 | Independent Review Entity |
| 2017 | D03 | Appeals Upheld | 01/01/2015 - 12/31/2015 | 1.5 | Independent Review Entity |
| 2016 | D03 | Appeals Upheld | 01/01/2014 - 12/31/2014 | 1.5 | Independent Review Entity |
| 2015 | D02 | Appeals Upheld | 01/01/2014 - 06/30/2014 | 1.5 | Independent Review Entity |